GRI Bio GRI
NASDAQ GRI
$2.00 -0.10 (-4.76%)
At close: Sep 29, 2026 · 4:00 PM EDT

GRI Bio (GRI) Total Debt (2020 - 2022)

Updated

GRI Bio (GRI) reported Total Debt of $602,000 for Q4 2022.

Analysis

GRI Bio (GRI) Total Debt (2020 - 2022) Analysis & Trends

  • By year, Total Debt came in at $61,000 in FY2020.
  • The Q4 2022 figure ranks as the lowest quarterly Total Debt since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 GRI Bio 3.79 Mn 3.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 602,000.00
Dec 31, 2020 61,000.00
API Access

GRI Bio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GRI&period=max&api_key=YOUR_API_KEY